What Is Going On With Emergent BioSolutions Shares?
What Is Going On With Emergent BioSolutions Shares?
Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals.
Emergent Biosolutions (NYSE:EBS)股价在周四交易中上涨，此前该公司宣布将其在巴尔的摩 - 卡姆登的设施出售给宝瑞制药。
What Happened: On Thursday prior to the market open, Emergent BioSolutions announced it entered into a definitive agreement with Bora to sell the site for about $30 million.
发生了什么：在周四开市之前，Emergent Biosolutions宣布与宝瑞达成了明确的协议，以约3000万美元的价格出售该工厂。
Besides the acquisition of the site, about 350 Emergent employees are anticipated to join Bora.
除了收购该站点外，预计将有约350名Emergent员工加入宝瑞。
The Baltimore-Camden site is a drug product facility that has clinical and commercial non-viral finish services across four fill lines, including lyophilization, formulation development, and additional support services.
巴尔的摩 - 卡姆登站点是一家药品生产厂，提供临床和商业的非病毒涂层服务，包括冻干、配方开发和其他支持服务。
"The decision to sell our Camden manufacturing facility is aligned with our multi-year plan to create a customer focused, leaner and more flexible organization, while we improve overall profitability and raise capital to reduce our debt," said Joe Papa, CEO at Emergent.
“出售我们的卡姆登制造设施的决定与我们的多年计划相一致，这个计划是为了打造以客户为中心，更精简、更灵活的组织，提高总体盈利能力并筹集资本以减少我们的债务，” Emergent的首席执行官Joe Papa表示。
The transaction is expected to close in the 2024 third quarter.
交易预计将在2024年第三季度结束。
Separately, Benchmark analyst Robert Wasserman maintains Emergent BioSolutions with a Buy and raises the price target from $5 to $8.
此外，Benchmark分析师Robert Wasserman将Emergent Biosolutions定为买入，并将目标价格从5美元升至8美元。
EBS Price Action: At the time of writing, Emergent BioSolutions is trading 6.85% at $6.47 per data from Benzinga Pro.
EBS价格走势：截至发布本文时，Emergent Biosolutions每股交易价格为6.47美元，上涨了6.85%，数据来自Benzinga Pro。
Image: Photo from Shutterstock.
图像来源: 来自 shutterstock 的照片。